API
Commercial
| Product Name | CAS No. | Indication |
| Celecoxib | 169590-42-5 |
Antiphlogistic |
| Rivaroxaban | 366789-02-8 | Cardiovascular |
| Baricitinib | 1187594-09-7 | Antiphlogistic |
| Vonoprazan Fumarate | 1260141-27-2 | The product is under patent and is intended for scientific research only |
| Calcium gluconate | 299-28-5 | Prevention and treatment of calcium deficiency |
| Netupitant | 290297-26-6 | Prevent nausea and vomiting during cancer chemotherapy |
| Crizotinib | 877399-52-5 | Anti-tumor |
| Favipiravir | 259793-96-9 | Anti-Virus |
| Dopamine Hydrochloride | 62-31-7 | Shock syndrome |
Under R&D Products
| Product Name | CAS No. | Indication |
| Rimegepant | 1289023-67-1 | Migraine |
| Upadacitinib | 1310726-60-3 | Antiphlogistic |
| Deucravacitinib | 1609392-27-9 | Antiphlogistic |
| Pacritinib | 937272-79-2 | Treatment of myelofibrosis |
| Etrasimod | 1206123-37-6 | Antiphlogistic |
| Semaglutide | 99291-20-0 | hypoglycemic |
| Tirzepatide | 2023788-19-2 | hypoglycemic |
